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Summary 
Bioartificial liver in the treatment of experimental acute hepatic failure in a large 
laboratory animal
Aim: To evaluate bioartificial liver (BAL) in the treatment of acute liver failure in the 
experiment.
Methods: 10 minipigs weight 25 – 30 kilograms with experimental acute liver failure (ALF) 
by surgical devascularization with portocaval by-pass were treated by BAL. The 
biochemical and hemodynamical parameters of ALF including intracranial pressure (ICP) 
were measured. The results were compared to control group without BAL treatment.
Results: To compare plasma bilirubin there was statistically significant difference between 
experimental and control groups in 6th and 9th hours to favourite BAL group  of minipigs 
(20,86 vs. 10,60, 22.29 vs. 11,75) and in the 12th hour (37,4 vs. 12,88). The value of ICP in 
both groups was not significant.
Conclusion: The functionality  of BAL on our own surgical model of ALF was proven. Initial 
85 % viability  of fresh isolated porcine hepatocytes and their survival in the time of BAL 
treatment was reached. Bilirubin plasma concentration has significantly changed in 
comparison in both groups. ICP values were not changed significantly. 
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